.
Pharma stock jumps 9% after receiving approval from India Drug Regulator to treat Bacteria Pneumonia

Pharma stock jumps 9% after receiving approval from India Drug Regulator to treat Bacteria Pneumonia

Pharma stock engaged in manufacturing injectables, finished dosage formulations, orals, biopharmaceuticals, and topicals jumped up to 9 percent in the day’s trade following the press release on India Drug Regulator approves Oral Antibiotic Miqnaf for Community-acquired Bacteria Pneumonia  Price Action  With a market capitalization of Rs. 25,035.97 Crores, the shares of Wockhardt Limited touched a [...]
×